US Stock Market Outlook: PPI Data and Tariff Decisions Ahead; Metals Surge, Mixed Chinese Stocks.

US Economic Data and Market Reactions

Upcoming Economic Reports

On Wednesday, the US will release the PPI and retail sales data for December. The reports are expected to show a 0.4% month-on-month increase in retail sales, indicating a recovery from the previous month.

Supreme Court Decision on Tariffs

The US Supreme Court may also rule on the legality of tariffs imposed by former President Trump. A delay in the ruling could favor Trump, presenting potential risks to the market.

Market Performance

US stock index futures are down, with the Dow futures falling 0.28%, Nasdaq futures down 0.5%, and S&P 500 futures down 0.39%.

Pre-Market Stock Movements

Most major tech stocks are down in pre-market trading, with Intel (INTC) up nearly 2% and Netflix (NFLX) up over 1%. Other stocks are showing slight declines.

Chinese Stocks Performance

Chinese stocks are mixed in pre-market trading. Alibaba (BABA) is up nearly 3%, while Trip.com (TCOM) is down nearly 15%.

Commodity and Cryptocurrency Trends

Precious Metals Surge

Gold, silver, and copper continue to rise, with several mining stocks also seeing gains.

Bitcoin Breaks $95,000

Bitcoin has surpassed $95,000, leading to a rise in some cryptocurrency stocks.

Corporate News Highlights

Alibaba's AI Ambitions

Alibaba Cloud aims to capture 80% of the incremental AI cloud market in China by 2026. The company is set to hold an app launch event on January 15.

Intel's Stock Surge

Intel's stock is up over 2% in pre-market trading following news of potential investment from Apple.

Tesla's Subscription Model

Tesla will stop offering a one-time purchase option for its Full Self-Driving (FSD) software after February 14, shifting to a monthly subscription model.

Rivian's Recall

Rivian Automotive (RIVN) is down nearly 3% after announcing a recall of over 19,000 vehicles due to safety concerns.

AstraZeneca's Acquisition

AstraZeneca (AZN) is up about 2% after acquiring Modella AI to enhance its oncology drug development.

Conclusion

The market is reacting to a mix of economic data expectations, corporate news, and geopolitical tensions. Investors should remain vigilant as these factors unfold.